ClinConnect ClinConnect Logo
Search / Trial NCT06581939

Impact of an Early and Extended Rehabilitation Program Combining Individually Tailored Nutrition and Physical Activities on Patient Outcomes After Invasive Mechanical Ventilation and Vasopressor Therapy in the ICU

Launched by NANTES UNIVERSITY HOSPITAL · Aug 29, 2024

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

Critical Care Nutritional Support Mechanical Ventilation Shock Macronutrients Rehabilitation Physiotherapy Adapted Physical Activity

ClinConnect Summary

The NUTRIREA-4 trial is studying whether a special rehabilitation program can help patients recover better after being on a ventilator and receiving medications for shock in the ICU. This program includes personalized nutrition, physiotherapy, and physical activities, starting early in the ICU and continuing at home after leaving the hospital. The goal is to see if this tailored approach leads to improved long-term health outcomes compared to the usual care that patients typically receive.

To participate in this trial, patients need to be 18 years or older, have started using a ventilator within the last 24 hours, and be receiving treatment for shock. They should also be able to give consent or have their family involved in the decision. Participants will either receive the early rehabilitation program or the standard care provided in their ICU. This trial is currently recruiting patients, and it aims to help improve recovery for those who have faced critical illnesses.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Invasive mechanical ventilation (MV) started in the ICU within the past 24 h, or started before ICU admission with ICU admission within the past 24 h, and expected to be required for at least 48 hours after randomization
  • Treatment with a vasoactive agent for shock (adrenaline, dobutamine, or noradrenaline)
  • Nutritional support expected to be started within 24 h after intubation (or within 24 h after ICU admission if intubation occurred before ICU admission)
  • Age 18 or older
  • Patient and/or next-of-kin informed about the trial and having consented to participation in the trial. If the patient is unable to receive information and no next-of-kin can be contacted during screening for the trial, trial inclusion will be completed as an emergency procedure by the ICU physician, in compliance with French law.
  • Covered by the French public health-insurance system
  • Exclusion Criteria:
  • MV started more than 24 hours earlier
  • Specific nutritional needs, such as pre-existing long-term home enteral or parenteral nutrition for chronic bowel disease
  • Dying patient, do-not-resuscitate order, or other treatment- limitation decision at ICU admission
  • Social circumstances hindering follow-up and telephone/video consultations (no fixed address, non-European residence)
  • Inability to provide a stable personal mobile phone number (temporary number or not in the owner's name)
  • Communication difficulties via telephone or video consultation (pre-existing severe hearing or visual impairment)
  • Pre-existing chronic illness with life expectancy \<6 months
  • Pre-existing cognitive impairment
  • Pre-existing spinal injury
  • Inability to walk before the critical illness
  • Acute or chronic neuromuscular disease
  • Brain injury, e.g., due to cardiac arrest, stroke, or severe trauma
  • Pregnancy, recent delivery, or lactation
  • Adult under guardianship
  • Correctional facility inmate
  • Institutionalized patient
  • Prior inclusion in a randomized trial designed to compare rehabilitation programs delivered to patients during critical illness

About Nantes University Hospital

Nantes University Hospital, a leading academic medical institution in France, is dedicated to advancing healthcare through innovative research and clinical trials. As a prominent sponsor of clinical studies, the hospital integrates cutting-edge scientific exploration with patient care, fostering collaborations among multidisciplinary teams of healthcare professionals and researchers. With a strong emphasis on ethical standards and patient safety, Nantes University Hospital aims to contribute to the development of effective therapies and interventions that enhance patient outcomes and overall public health.

Locations

Tours, , France

Grenoble, , France

Montpellier, , France

Suresnes, , France

Amiens, , France

Nice, , France

Rennes, , France

Lille, , France

Besançon, , France

Nantes, , France

Clermont Ferrand, , France

Angers, , France

Reims, , France

Valenciennes, , France

Rouen, , France

Dijon, , France

Lyon, , France

Argenteuil, , France

Dieppe, , France

Strasbourg, , France

Saint Priest En Jarez, , France

Lens, , France

Le Mans, , France

Vannes, , France

Bordeaux, , France

Tarbes, , France

Cholet, , France

Saint Denis, , France

Verdun, , France

Belfort, , France

Haguenau, , France

Strasbourg, , France

Béthune, , France

Paris, , France

Saint Malo, , France

Orléans, , France

Paris, , France

Albi, , France

Amiens, , France

Angoulême, , France

Garches, , France

La Roche Sur Yon, , France

Le Kremlin Bicêtre, , France

Lomme, , France

Lorient, , France

Melun, , France

Paris, , France

Paris, , France

Paris, , France

Saint Brieuc, , France

épagny, , France

Nice, , France

Patients applied

0 patients applied

Trial Officials

Jean REIGNIER, MD, PhD

Principal Investigator

Nantes University Hospital

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported